Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation

British Journal of Dermatology

Volumn 156, Issue SUPPLE. 1, 2006, Pages 7-12

  Hexsel, D ^a   Arellano, I ^b   Rendon, M ^c  

^a UNIVERSITY OF PASSO FUNDO   (Brazil)

^b UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^c Dermatology and Aesthetic Center   (United States)

Author keywords

Hispanic; Hyperpigmentation; Latin American; Melasma; Treatment

Indexed keywords

ARCTOSTAPHYLOS UVA URSI EXTRACT; AZELAIC ACID; CORTICOSTEROID; FLUOCINOLONE ACETONIDE; HYDROQUINONE; LACTIC ACID; MELANIN; ORAL CONTRACEPTIVE AGENT; PLACEBO; RETINOIC ACID; SALICYLIC ACID; SUNSCREEN;

ALLERGIC REACTION; ARTICLE; CHLOASMA; CLINICAL TRIAL; DRY SKIN; ERYTHEMA; ETHNIC DIFFERENCE; ETHNOLOGY; HISPANIC; HUMAN; HYPERPIGMENTATION; LOW LEVEL LASER THERAPY; OCHRONOSIS; POSTINFLAMMATORY HYPERPIGMENTATION; PRIORITY JOURNAL; PRURITUS; SKIN ATROPHY; SKIN BURNING SENSATION; SKIN INFLAMMATION; SKIN IRRITATION; TELANGIECTASIA; TOPICAL TREATMENT; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; DRUG THERAPY, COMBINATION; FACIAL DERMATOSES; FLUOCINOLONE ACETONIDE; GLUCOCORTICOIDS; HISPANIC AMERICANS; HUMANS; HYDROQUINONES; HYPERPIGMENTATION; KERATOLYTIC AGENTS; LATIN AMERICA; SALICYLIC ACID; SKIN PIGMENTATION; TRETINOIN;

EID: 33751318179     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07589.x     Document Type: Article

References (29)

1. Hay RJ, Castanon RE, Hernandez HA, Lopez GC, Fuentes LFL, Solis SP, Andersson N. Wastage of family income on skin disease in Mexico. BMJ 1994; 309:848.
2. Taylor SC. Epidemiology of skin diseases in ethnic populations. Dermatol Clin 2003; 21:601-7.
3. Berardesca E, de Rigal J, Leveque JL, Maibach HI. In vivo biophysical characterization of skin physiological differences in races. Dermatologica 1991; 182:89-93.
4. Fitzpatrick TB. The validity and practicality of skin reactive skin type I through VI. Arch Dermatol 1988; 124:869-71.
5. Fitzpatrick TB, Ortonne J-P. Normal skin color and general considerations of pigmentary disorders. In: Fitzpatrick's Dermatology in General Medicine, Vol. 1, 6th edn (Freedberg I, Eisen A, Wolff K, Frank Austen K, Goldsmith L, Katz S, eds.). New York: McGraw-Hill, 2003:820.
6. Lancer HA. Lancer Ethnicity Scale (LES). Lasers Surg Med 1998; 22:9.
7. Obagi ZE, Alaiti S, Obagi S et al. Standardizing the evaluation of treatment outcomes after skin rejuvenation: the qualitative scoring system. Aesthetic Plast Surg 2000; 24:165-70.
8. Toda K, Patnak MA, Parrish A, Fitzpatrick TB. Alteration of racial differences in melanosome distribution in human epidermis after exposure to ultraviolet light. Nat New Biol 1972; 236:143-5.
9. Goldschmidt H, Raymond JZ. Quantitative analysis of skin color from melanin content of superficial skin cells. J Forensic Sci 1972; 17:124-31.
10. Olson RL, Gaylor J, Everett MA. Skin color, melanin, and erythema. Arch Dermatol 1973; 108:541-4.
11. Smit NP, Kolb RM, Lentjes EGWM, Noz KC, van der Meulen H, Koerten HK et al. Variations in melanin formation by cultured melanocytes from different skin types. Arch Dermatol Res 1998; 290:342-9.
12. Montagna W, Carlisle K. The architecture of black and white facial skin. J Am Acad Dermatol 1991; 24:929-37.
13. Herzberg AJ, Dinehart SM. Chronologic aging in black skin. Am J Dermatopathol 1989; 11:319-28.
14. Reed JT, Ghadially R, Elias PM. Skin type, but neither race nor gender, influence epidermal permeability barrier function. Arch Dermatol 1995; 131:1134-8.
15. La Ruche G, Cesarini JP. Histology and physiology of black skin. Ann Dermatol Venereol 1992; 119:567-74, in French.
16. Arellano I., León G., Luna C. Quality of life in Mexican patients with melasma. Cosmet Dermatol 2006; 5:343-5.
17. Dominguez A, Balkirshnan R, Ellzey A. Melasma in Latina patients: cross-cultural adaptation and validation of a quality-of-life questionnarie in Spanish language. J Am Acad Dermatol 2006; 55:59-66.
18. Sanchez MR. Cutaneous diseases in Latinos. Dermatol Clin 2003; 21:689-97.
19. Hexsel D et al. A Review of Clinical Data from 100 Brazilian Patients Affected by Melasma. Chicago, IL: Poster Presented at AAD, 2005.
20. Mandry Pagan R, Sanchez JL. Mandibular melasma. P R Health Sci J 2000; 19:231-4.
21. Ennes SBP, Paschoalick RC, Mora M. A double-blind, comparative, placebo-controlled study of the efficacy and tolerability of 4% hydroquinone as a depigmenting agent in melasma. J Dermatol Treat 2000; 11:173-9.
22. Cestari TF et al. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. J Cosmet Dermatol (in press).
23. Vazquez M, Sanchez JL. The efficacy of a broad-spectrum sunscreen in the treatment of melasma. J Dermatol Treat 1996; 7:235-7.
24. Ortiz Y, Benuto RE, del Pino ME, Guzmán G, Arias I. Melasma: estudio comparativo doble ciego al azar para evaluar la eficacia y seguridad de UVA Ursi, UVA ursi y ácido láctico versus hidroquinona. Dermatologia Rev Mex 1999; 43:245-54.
25. Verallo-Rowell VM, Verallo V, Graupe K, Lopez-Villafuerte L, Garcia-Lopez M. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol Suppl (Stockh) 1989; 143:58-61.
26. Balina LM, Graupe K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol 1991; 30:893-5.
27. Grimes PE, Kelly P, Torok H, Willis IA. Community-based trial of a triple-combination agent for the treatment of facial melasma. Cutis 2006; 77:177-84.
28. Grimes PE. The safety and efficacy of salicyclic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 1999; 25:18-22.
29. Rendon M, Berneburg M, Arellano I, Picardo M. Treatment of melasma. J Am Acad Dermatol 2006; 54(5 Suppl. 2):S272-81.